Safety and efficacy of modified dose-attenuated FOLFIRINOX chemotherapy in patients over 65 years with advanced pancreatic adenocarcinoma.
Matheus Bongers Alessandretti
No relevant relationships to disclose
Erika Pereira Brandao
No relevant relationships to disclose
Carina Meira Abrahão
No relevant relationships to disclose
Aline Rocha Lino
No relevant relationships to disclose
Rodnei Macambira Junior
No relevant relationships to disclose
Marcos André Costa
No relevant relationships to disclose
Marcelo Rocha Cruz
No relevant relationships to disclose